Ixempra



Indications and Reactions:

Role Indications Reactions
Primary
Breast Cancer Metastatic 38.1%
Breast Cancer 24.7%
Premedication 14.4%
Prostate Cancer 5.7%
Endometrial Cancer 2.6%
Diabetes Mellitus 1.5%
Endometrial Adenocarcinoma 1.5%
Hypertension 1.5%
Nausea 1.5%
Non-small Cell Lung Cancer 1.5%
Breast Cancer Stage Iv 1.0%
Pancreatic Carcinoma Metastatic 1.0%
Uterine Cancer 1.0%
Anxiety 0.5%
Blood Cholesterol Increased 0.5%
Breast Cancer Recurrent 0.5%
Depression 0.5%
Hypotonia 0.5%
Malignant Melanoma 0.5%
Tobacco User 0.5%
Malignant Neoplasm Progression 11.7%
Neuropathy Peripheral 10.2%
Incorrect Storage Of Drug 8.6%
Vomiting 8.6%
Death 5.5%
Flushing 4.7%
Hypersensitivity 4.7%
Infusion Related Reaction 4.7%
White Blood Cell Count Decreased 4.7%
Circumstance Or Information Capable Of Leading To Medication Error 3.9%
Myalgia 3.9%
Pancytopenia 3.9%
Rash 3.9%
Adverse Event 3.1%
Bone Pain 3.1%
Nausea 3.1%
Neutropenia 3.1%
Recall Phenomenon 3.1%
Stomatitis 3.1%
Full Blood Count Decreased 2.3%
Secondary
Product Used For Unknown Indication 38.5%
Endometrial Cancer 23.1%
Breast Cancer Metastatic 15.4%
Neoplasm 15.4%
Breast Cancer 7.7%
Constipation 25.0%
Neuropathy Peripheral 25.0%
Stomatitis 25.0%
Weight Decreased 25.0%
Concomitant
Breast Cancer 25.6%
Breast Cancer Metastatic 17.9%
Product Used For Unknown Indication 7.7%
Bone Cancer 5.1%
Her-2 Positive Breast Cancer 5.1%
Metastases To Bone 5.1%
Metastatic Neoplasm 5.1%
Pain 5.1%
Anxiety 2.6%
Asthma 2.6%
Breast Cancer Male 2.6%
Depression 2.6%
Disease Progression 2.6%
Inflammatory Carcinoma Of The Breast 2.6%
Nausea 2.6%
Neutropenia 2.6%
Prostate Cancer 2.6%
Pain 14.3%
Vomiting 14.3%
Weight Decreased 14.3%
Disease Progression 7.1%
Drug Administration Error 7.1%
Hypocalcaemia 7.1%
Metastatic Neoplasm 7.1%
Pain In Extremity 7.1%
Protein Urine Present 7.1%
Skin Ulcer 7.1%
Vaginal Haemorrhage 7.1%